Video
VIDEO: Advocacy efforts spur CMS to drop HCAHPS pain domain assessment
How pain management is assessed is changing in Hospital Consumer Assessment of Healthcare Providers and Systems survey scores, thanks in part to...
Video
VIDEO: Low-tech system tweaks help hospitalists minimize workflow disruptions
Physicians are interrupted an average of 15 times per hour. Here are some strategies for streamlining workflow in the hospital.
News
Trends in value-based care favor hospitalists, expert says
An emphasis on value-based care means hospitalists are needed more than ever.
News
Shark Tank returns: Which GI innovations will make it to market?
BOSTON – A wide range of GI products in development were analyzed by a panel of expert “sharks.”
News
White House pick for mental health czar causes stir
The congressman who crafted the legislation creating the role of a U.S. mental health czar criticizes the president’s choice for the role.
News
Precision medicine taking shape in GI
BOSTON – Questions surround the use of personalized medicine to predict a variety of GI cancer risks, but a panel of experts discussed how its use...
News
The future of GI: A choice between ‘care assembly’ or skilled risk management
Since the goal of value-based care is to drive down the cost of services, the gastroenterologist’s competitive advantage is in the knowledge of...
News
FDA warns against use of codeine, tramadol in children
Commonly used cough and cold, and pain medications for children will now carry stringent warnings.
News
Empirical evidence lags behind rise in preadolescents presenting with gender dysphoria
SCOTTSDALE, ARIZ. – Which of three approaches is preferred for the treatment of preadolescent gender dysphoria?
News
Novel antifungal had favorable safety, efficacy profile for onychomycosis in phase IIB study
ORLANDO – A new antifungal is set to move to phase III studies after meeting study endpoints with significant separation from controls, in...
News
Ixekizumab found superior to ustekinumab in psoriasis at 24 weeks
ORLANDO – At 24 weeks, the IL-17A blocker ixekizumab was superior to the IL-12/IL-23 blocker ustekinumab in moderate to severe plaque psoriasis....
News
Dupilumab improved eczema scores in children in open label trial
ORLANDO – Dupilumab is effective and well tolerated in children and adolescents with atopic dermatitis.
News
Are new medications on horizon for patients with depression, inflammation?
SCOTTSDALE, ARIZ. – The immune system could hold clues as to which antidepressants will work best in which patients, according to a psychiatrist...
News
Adalimumab for psoriasis: Blocking TNF-alpha had no effect on vascular inflammation
A study evaluating the effects of blocking TNF-alpha on vascular inflammation in adults with psoriasis raises more questions than answers.
Video
VIDEO: Stress alleviation strategies boost inflammatory skin treatment regimens
ORLANDO – Is there now a scientific basis for incorporating stress alleviation techniques into the care of patients with inflammatory skin...